Infliximab infusion is not yet FDA-approved for psoriasis but has been reported to be very effective for plaque psoriasis. We report 2 patients without a history of psoriasis who after administration of infliximab for their inflammatory bowel disease experienced new onset, biopsy confirmed psoriasis.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
psoriasis
5
infliximab associated
4
associated new-onset
4
new-onset psoriasis
4
psoriasis infliximab
4
infliximab infusion
4
infusion fda-approved
4
fda-approved psoriasis
4
psoriasis reported
4
reported effective
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!